Neurogene, Inc. Common Stock Made Headway

Mon, Nov 04, 2024 at 07:34 PM
Neurogene, Inc. Common Stock Made Headway

Neurogene, Inc. Common Stock (NGNE:NASDAQ) jumped higher at $66, representing a gain of 43.3%. On Mon, Nov 04, 2024, NGNE:NASDAQ hit a New 2-Week High of $66. The stock appeared on our News Catalysts scanner on Mon, Nov 04, 2024 at 10:07 AM in the 'PRIVATE PLACEMENT' category. From Tue, Oct 22, 2024, the stock recorded 44.44% Up Days and 30.00% Green Days

About Neurogene, Inc. Common Stock (NGNE:NASDAQ)

Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.